BONFANTI PAOLO

Fusco, F., Mastrorosa, I., Vichi, F., Cervo, A., Saracino, A., Calza, L., et al. (2026). HIV INFECTION AMONG ADOLESCENTS AND YOUNG ADULTS IN ITALY: EPIDEMIOLOGY, VIRO-IMMUNOLOGICAL AND TREATMENT OUTCOMES. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 163(February 2026) [10.1016/j.ijid.2025.108200]. Dettaglio

Altobelli, D., Ricci, E., Maggi, P., Santoro, C., Orofino, G., Menzaghi, B., et al. (2025). Smoking cessation in people living with HIV: results from Italian STOPSHIV Project cohort.. Intervento presentato a: XII Workshop Nazionale CISAI, Milano. Dettaglio

Faltoni, M., Ricci, E., Mezzadri, L., Corti, N., Bisi, L., Fois, M., et al. (2025). Comparison of meropenem-vaborbactam vs ceftazidime-avibactam in the treatment of KPC producing Klebsiella pneumoniae infections. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

Squillace, N., Ricci, E., Maggi, P., Taramasso, L., Menzaghi, B., Sarchi, E., et al. (2025). Safety and durability of treatment with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a real-life cohort. Intervento presentato a: 20th European AIDS Conference (EACS), Parigi. Dettaglio

Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M., Moschese, D., et al. (2025). Potential for replacing protease inhibitor with doravirine in cART-experienced subjects successfully treated with darunavir-cobicistat plus dolutegravir dual regimen. Intervento presentato a: 20th European AIDS Conference (EACS), Parigi. Dettaglio